|
Davis, Darren W; Shen, Yu; Mullani, Nizar A et al. (2004) Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors. Clin Cancer Res 10:33-42
|
|
Davis, Darren W; Inoue, Keiji; Dinney, Colin P N et al. (2004) Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts. Cancer Res 64:4601-10
|
|
Santamaria, A B; Davis, D W; Nghiem, D X et al. (2002) p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells. Cell Death Differ 9:549-60
|
|
Watson, V E; Hill, L L; Owen-Schaub, L B et al. (2000) Apoptosis in mycobacterium tuberculosis infection in mice exhibiting varied immunopathology. J Pathol 190:211-20
|
|
Davis, D W; Weidner, D A; Holian, A et al. (2000) Nitric oxide-dependent activation of p53 suppresses bleomycin-induced apoptosis in the lung. J Exp Med 192:857-69
|
|
Shaheen, R M; Davis, D W; Liu, W et al. (1999) Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res 59:5412-6
|
|
Davis, D W; Hamilton Jr, R F; Holian, A (1997) 4-Hydroxynonenal inhibits interleukin-1 beta converting enzyme. J Interferon Cytokine Res 17:205-10
|
